Manchester Capital Management »

Adial Pharmaceuticals shares owned by Manchester Capital Management

Quarter-by-quarter ownership of Adial Pharmaceuticals (ADIL) shares owned by Manchester Capital Management from 13F filings

Historical chart of Manchester Capital Management investment in Adial Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Adial Pharmaceuticals held by Manchester Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adial Pharmaceuticals by Manchester Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $64k 48k 1.33
2023-12-31 $90k 48k 1.86
2023-09-30 $134k 48k 2.78

More positions owned by Manchester Capital Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
United Parcel Service CL B (UPS)
Apple (AAPL)
T. Rowe Price (TROW)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Value Etf (VTV)
Microsoft Corporation (MSFT)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Msci Kld400 Soc (DSI)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Vanguard Index Fds Mid Cap Etf (VO)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Manchester Capital Management

Top funds holding Adial Pharmaceuticals

Manchester Capital Management
Hrt Financial
BlackRock
UBS Group
Tower Research Capital
Advisor Group Holdings
Headlands Technologies
Benjamin F. Edwards & Company
Royal Bank of Canada
Morgan Stanley
Wells Fargo & Company
Qube Research & Technologies

View all funds holding Adial Pharmaceuticals